ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Scrip's Five Must-Know Things - 4 March 2024"
Episode Synopsis
Audio roundup of selected biopharma industry content from Scrip over the past business week. In this episode: optimistic outlook for biopharma IPOs; Boehringer’s promising MASH results; Viking emerges as obesity contender; Incyte looks to portfolio diversification; and a look at China’s HPV vaccine market.
https://scrip.citeline.com/SC149879/Quick-Listen-Scrips-Five-MustKnow-Things
https://scrip.citeline.com/SC149879/Quick-Listen-Scrips-Five-MustKnow-Things
More episodes of the podcast Citeline Podcasts
Datamonitor Healthcare Podcast: ESMO 2025
12/11/2025
Scrip's Five Must-Know Things - Nov. 4, 2025
04/11/2025
Drug Fix: US FDA Streamlines Biosimilar Development Requirements, Clarifies Inspection Reform
31/10/2025
In God we trust